// June 26, 2023
Complex generics: Are global regulators addressing the needs?
The development of generic versions of innovator medicines is a global public health need.
The development of generic versions of innovator medicines is a global public health need.
Interest in innovative vaccines that use messenger ribonucleic acid (mRNA) and viral vectored tec
Desmond Hunt, Ph.D., USP’s Senior Scientific Liaison, provides insight into packaging
USP Principal Scientific Liaison Margareth Marques, Ph.D., provides answers to questi